Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
0.9600
-0.0112 (-1.15%)
At close: Jul 13, 2026, 4:00 PM EDT
0.9500
-0.0100 (-1.04%)
Pre-market: Jul 14, 2026, 6:33 AM EDT
Canopy Growth Revenue
In the fiscal year ending March 31, 2026, Canopy Growth had annual revenue of 284.60M CAD with 5.80% growth. Canopy Growth had revenue of 71.25M in the quarter ending March 31, 2026, with 9.56% growth.
Revenue (ttm)
284.60M CAD
Revenue Growth
+5.80%
P/S Ratio
2.01
Revenue / Employee
252,308 CAD
Employees
1,128
Market Cap
409.08M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 284.60M | 15.61M | 5.80% |
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
| Mar 31, 2019 | 226.34M | 148.39M | 190.37% |
| Mar 31, 2018 | 77.95M | 38.05M | 95.38% |
| Mar 31, 2017 | 39.90M | 27.20M | 214.16% |
| Mar 31, 2016 | 12.70M | 10.33M | 435.60% |
| Mar 31, 2015 | 2.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 858.28M |
| Emergent BioSolutions | 676.80M |
| Organogenesis Holdings | 514.70M |
| Ironwood Pharmaceuticals | 361.51M |
| Evolus | 301.79M |
| Akebia Therapeutics | 232.40M |
| Kamada | 181.68M |
| Anika Therapeutics | 116.26M |
CGC News
- 5 days ago - Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? - The Motley Fool
- 6 days ago - Canopy Growth: Is Another Reverse Stock Split Inevitable? - The Motley Fool
- 6 days ago - Canopy Growth Slides: Investor presentation - Filings
- 7 days ago - Top Canadian Marijuana Stock Picks For Investors Today - MarijuanaStocks
- 9 days ago - Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So. - The Motley Fool
- 15 days ago - Canopy Growth's Medical Marijuana Sales Are Soaring. Is the Beaten-Down Stock Ready to Rebound? - The Motley Fool
- 20 days ago - Leading Canadian Marijuana Stocks Showing Momentum in 2026 - MarijuanaStocks
- 26 days ago - 3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year - MarijuanaStocks